From Bench to Clinic: China’s Strategic Five-Pillar Pathway for Engineering-Led Regenerative Medicine

Yu Peng; Yizhi Zhang; Xiaoyan Sun; Xiaobing Fu; Yufeng Jiang

doi:10.1016/j.eng.2025.12.017

Engineering ›› :202512017 DOI: 10.1016/j.eng.2025.12.017

Views & Comments

research-article

From Bench to Clinic: China’s Strategic Five-Pillar Pathway for Engineering-Led Regenerative Medicine

Yu Peng ^a^,^b
, Yizhi Zhang ^a^,^b
, Xiaoyan Sun ^a
, Xiaobing Fu ^a^,^b^,^*
, Yufeng Jiang ^a^,^c^,^*

Author information +

History +

PDF (656KB)

Cite this article

Download citation ▾

Yu Peng, Yizhi Zhang, Xiaoyan Sun, Xiaobing Fu, Yufeng Jiang. From Bench to Clinic: China’s Strategic Five-Pillar Pathway for Engineering-Led Regenerative Medicine. Engineering 202512017 DOI:10.1016/j.eng.2025.12.017

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Fu X. Wound care in China: from repair to regeneration. Int J Low Extrem Wounds 2012; 11(3):143-5.

[2]	Eming SA, Martin P, Tomic-Canic M. Wound repair and regeneration: mechanisms, signaling, and translation. Sci Transl Med 2014; 6(265):265sr6.

[3]	Sun X, Xiang J, Chen R, Geng Z, Wang L, Liu Y, et al. Sweat gland organoids originating from reprogrammed epidermal keratinocytes functionally recapitulated damaged skin. Adv Sci 2021; 8(22):e2103079.

[4]	Huang Q, Chu Z, Wang Z, Li Q, Meng S, Lu Y, et al. circCDK13-loaded small extracellular vesicles accelerate healing in preclinical diabetic wound models. Nat Commun 2024; 15(1):3904.

[5]	Hao M, Su J, Rui W, Qi S, Ying L, Jiang Y, et al. Clinical epidemiology study of chronic cutaneous wounds: an analysis of 889 inpatients. Acad J Chin PLA Med Sch 2022; 43:253-8. Chinese.

[6]	Yuan J, Hou Q, Zhong L, Dai X, Lu Q, Li M, et al. Sustained release of inhibitor from bionic scaffolds for wound healing and functional regeneration. Biomater Sci 2020; 8(20):5647-55.

[7]	Cai C, Zhu H, Chen Y, Guo Y, Yang Z, Li H, et al. Mechanoactive nanocomposite hydrogel to accelerate wound repair in movable parts. ACS Nano 2022; 16(12):20044-56.

[8]	Smole A, Lainšček D, Bezeljak U, Horvat S, Jerala R. “A synthetic mammalian therapeutic gene circuit for sensing and suppressing inflammation,” molecular therapy. Mol Ther 2017; 25(1):102-19.

[9]	Henn D, Zhao D, Sivaraj D, Trotsyuk A, Bonham CA, Fischer KS, et al. Cas9-mediated knockout of Ndrg2 enhances the regenerative potential of dendritic cells for wound healing. Nat Commun 2023; 14(1):4729.

[10]	Guri-Lamce I, AlRokh Y, Kim Y, Maeshima R, Graham C, Hart SL, et al. Topical gene editing therapeutics using lipid nanoparticles: ‘gene creams’ for genetic skin diseases? Br J Dermatol 2024; 190(5):617-27.

[11]	Bolsoni J, Liu D, Mohabatpour F, Ebner R, Sadhnani G, Tafech B, et al. Lipid nanoparticle-mediated hit-and-run approaches yield efficient and safe in situ gene editing in human skin. ACS Nano 2023; 17(21):22046-59.

[12]	Peng Y, Jiang Y, Fu X. Next-generation skin regeneration: opportunities and challenges in biomaterials and bioengineering. Sci Bull 2023; 68(16):1722-5.

[13]	Xiong M, Yang X, Shi Z, Xiang J, Gao H, Ji S, et al. Programmable artificial skins accomplish antiscar healing with multiple appendage regeneration. Adv Mater 2024; 36(50):e2407322.

[14]	Kadauke S, Bonamino MH, Levine BL, Harrison R, Karnieli O. In-hospital manufacturing of cellular therapies using automated systems. Clin Chem 2023; 69(9):954-60.

[15]	Aifuwa I. PAT strategies and applications for cell therapy processing. Curr Opin Biomed Eng 2022; 24:100405.

[16]	Wu W, Wang Y, Tang Z, Gao Y, Huo Y. Regulatory oversight of cell therapy in China: government’s efforts in patient access and therapeutic innovation. Pharmacol Res 2020; 158:104889.

[17]	Esdaille CJ, Washington KS, Laurencin CT. Regenerative engineering: a review of recent advances and future directions. Regen Med 2021; 16(5):495-512.